news UK offers genomics expertise to identify new SARS-CoV-2 variants 29 January 2021 | By Victoria Rees (Drug Target Review) The UK Government has said genomics expertise will be offered to countries around the world to identify new variants of SARS-CoV-2.
news Heparin inhibits SARS-CoV-2 invasion, finds study 29 January 2021 | By Hannah Balfour (Drug Target Review) Research suggests heparin could be repurposed for COVID-19 because it can bind to the SARS-CoV-2 Spike protein and prevent the virus from infecting cells in vitro.
news Recovered COVID-19 patients may be protected, but they could still transmit the virus 15 January 2021 | By Hannah Balfour (Drug Target Review) According to a Public Health England study, prior SARS-CoV-2 infection provides 83 percent protection against reinfection but may not stop individuals spreading COVID-19.
news UK organisations call for investigation of ethnicity and COVID-19 incidence and outcome 24 April 2020 | By Hannah Balfour (Drug Target Review) The UK National Institute of Health Research (NIHR) and UK Research and Innovation (UKRI) wish to fund research exploring if people from black, Asian and middle eastern backgrounds are disproportionately at risk from COVID-19.
news Wildlife conservation plans must consider Lyme disease risk 19 May 2017 | By Niamh Marriott (Drug Target Review) Lyme disease – an infection contracted from the bite of an infected tick– is an important emerging disease in the UK, and is increasing in incidence in people in the UK and large parts of Europe and North America.
news NHS announces £42 million pharmacy integration fund 27 October 2016 | By Niamh Louise Marriott, Digital Content Producer NHS England has announced a £42m fund to support pharmacy to transform how it operates across the NHS for the benefit of patients over the next two years...
news PHE spins out its drug development and production as a new company – Porton Biopharma Limited 9 July 2015 | By Victoria White The transfer of PHE's clinical drug development and production capability into Porton Biopharma Ltd has been approved by the Secretary of State for Health...
news Ebola virus mutated slower than first thought 18 June 2015 | By Victoria White The Ebola virus responsible for the outbreak in West Africa mutated at a similar rate to previous outbreaks, according to a new study led by PHE...